BMRA Competitors & Alternatives
Compare BIOMERICA INC with similar stocks in the same industry
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
BMRA
Main Stock$2.11
Tradestie Score
54
Market Cap
$8.09M
Revenue Growth
-0.2%
Analyst Upside
+516.6%
Top Competitors
19 stocks in IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
IDXX
Idexx Laboratories Inc
|
$562.05
|
$49.61B | 42.9 | 59 | Compare |
|
LNTH
Lantheus Holdings, Inc
|
$76.14
|
$3.51B | 22.2 | 58 | Compare |
|
QDEL
QuidelOrtho Corporation Common Stock
|
$17.02
|
$2.12B | - | 50 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$12.97
|
$2.01B | - | 56 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$30.20
|
$1.68B | - | 55 | Compare |
|
NNNN
Anbio Biotechnology Class A Ordinary Shares
|
$25.92
|
$1.53B | 428.2 | 52 | Compare |
|
NEOG
Neogen Corp
|
$9.23
|
$1.26B | - | 62 | Compare |
|
MYGN
Myriad Genetics Inc
|
$4.62
|
$719.23M | - | 51 | Compare |
|
TKNO
Alpha Teknova, Inc. Common Stock
|
$3.10
|
$340.89M | - | 62 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$3.23
|
$158.43M | - | 53 | Compare |
More BMRA Analysis
Data updated: Apr 02, 2026 | Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES (SIC 2835)
19 stocks in this industry